A detailed history of Susquehanna International Group, LLP transactions in Co Diagnostics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 187,569 shares of CODX stock, worth $195,071. This represents 0.0% of its overall portfolio holdings.

Number of Shares
187,569
Previous 201,570 6.95%
Holding current value
$195,071
Previous $251,000 6.77%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.02 - $1.75 $14,281 - $24,501
-14,001 Reduced 6.95%
187,569 $234,000
Q2 2024

Aug 15, 2024

BUY
$1.01 - $1.7 $107,976 - $181,741
106,907 Added 112.93%
201,570 $251,000
Q1 2024

May 07, 2024

SELL
$1.06 - $1.42 $13,818 - $18,511
-13,036 Reduced 12.1%
94,663 $106,000
Q4 2023

Feb 14, 2024

BUY
$1.0 - $1.5 $26,414 - $39,621
26,414 Added 32.5%
107,699 $143,000
Q3 2023

Nov 14, 2023

BUY
$1.03 - $1.85 $46,272 - $83,111
44,925 Added 123.56%
81,285 $86,000
Q2 2023

Aug 11, 2023

BUY
$1.04 - $1.64 $3,637 - $5,736
3,498 Added 10.64%
36,360 $40,000
Q1 2023

May 16, 2023

SELL
$1.39 - $3.24 $132,432 - $308,691
-95,275 Reduced 74.35%
32,862 $48,000
Q4 2022

Feb 14, 2023

SELL
$2.32 - $3.68 $72,843 - $115,544
-31,398 Reduced 19.68%
128,137 $322,000
Q3 2022

Nov 14, 2022

BUY
$2.87 - $7.01 $328,244 - $801,740
114,371 Added 253.23%
159,535 $512,000
Q2 2022

Aug 15, 2022

SELL
$3.76 - $6.29 $217,474 - $363,807
-57,839 Reduced 56.15%
45,164 $253,000
Q1 2022

May 16, 2022

SELL
$5.03 - $9.61 $1.41 Million - $2.7 Million
-280,569 Reduced 73.15%
103,003 $637,000
Q4 2021

Feb 14, 2022

SELL
$8.12 - $10.37 $328,153 - $419,082
-40,413 Reduced 9.53%
383,572 $3.43 Million
Q3 2021

Nov 15, 2021

BUY
$7.48 - $11.38 $1.73 Million - $2.64 Million
231,560 Added 120.34%
423,985 $4.13 Million
Q2 2021

Aug 11, 2021

SELL
$7.16 - $9.56 $139,691 - $186,515
-19,510 Reduced 9.21%
192,425 $1.59 Million
Q1 2021

May 17, 2021

BUY
$8.52 - $19.21 $1.7 Million - $3.82 Million
198,977 Added 1535.55%
211,935 $2.02 Million
Q4 2020

Feb 16, 2021

SELL
$9.3 - $15.19 $2.5 Million - $4.08 Million
-268,809 Reduced 95.4%
12,958 $121,000
Q3 2020

Nov 16, 2020

BUY
$8.24 - $30.8 $1.12 Million - $4.2 Million
136,405 Added 93.84%
281,767 $3.83 Million
Q2 2020

Aug 14, 2020

BUY
$7.46 - $23.42 $701,993 - $2.2 Million
94,101 Added 183.57%
145,362 $2.81 Million
Q1 2020

May 15, 2020

BUY
$0.91 - $17.81 $46,647 - $912,958
51,261 New
51,261 $391,000

Others Institutions Holding CODX

About Co-Diagnostics, Inc.


  • Ticker CODX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 33,781,000
  • Market Cap $35.1M
  • Description
  • Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and ...
More about CODX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.